Attached files
file | filename |
---|---|
EX-99.2 - EX-99.2 - MEDCATH CORP | g26064exv99w2.htm |
EX-99.1 - EX-99.1 - MEDCATH CORP | g26064exv99w1.htm |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934.
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934.
Date of Report (Date of earliest event reported): February 9, 2011
MEDCATH CORPORATION
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
000-33009 (Commission File Number) |
56-2248952 (IRS Employer Identification No.) |
10720 Sikes Place
Charlotte, North Carolina 28277
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)
(704) 815-7700
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. | Results of Operations and Financial Condition |
On February 9, 2011, MedCath Corporation issued a press release announcing its results of
operations for the fiscal quarter ended December 31, 2010. A copy of the press release and
supplemental financial information are furnished as Exhibits 99.1 and 99.2, respectively.
Item 9.01. | Financial Statements and Exhibits |
Exhibit 99.1 Press Release dated February 9, 2011
Exhibit 99.2 Supplemental Financial Information
Exhibits 99.1 and 99.2 listed in this Item 9.01 are being furnished under Item 2.02 and shall not
be deemed filed for purpose of Section 18 of the Securities Exchange Act of 1934, as amended, nor
shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as
amended, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDCATH CORPORATION |
||||
Date: February 9, 2011 | By: | /s/ James A. Parker | ||
James A. Parker | ||||
Executive Vice President and Chief Financial Officer |
INDEX TO EXHIBITS
Exhibit No. | Description | |
Exhibit 99.1
|
Press Release dated February 9, 2011 | |
Exhibit 99.2
|
Supplemental Financial Information |